Simon Rule

17PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.

Findlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf

|Apr 28, 2021
Pooled analysis of safety data from clinical trials evaluating acalabrutinib monotherapy in mature B-cell malignancies.

Richard R Furman, John C Byrd, Roger G Owen

|Apr 26, 2021
Phase I, first-in-human trial of Bruton's tyrosine kinase inhibitor M7583 in patients with B-cell malignancies.

Wojciech Jurczak, Simon Rule, William Townsend

|Aug 13, 2020
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study.

Carlo Visco, Alice Di Rocco, Andrea Evangelista

|Aug 09, 2020
Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

Graeme A M Fraser, Asher Chanan-Khan, Fatih Demirkan

|Dec 19, 2018
Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma.

Simon Rule, Gordon Cook, Nigel H Russell

Pageof 3

Frequent Collaborators

3 joint publications

Gilles Salles

3 joint publications

Luca Arcaini

2 joint publications

Jennifer R Brown

2 joint publications

Michael Wang